Donald Trump’s new drug pricing order has the Indian pharmaceutical industry on edge. While CDMOs may benefit, generics and ...

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to ...

Michael Lämmerhofer from the Institute of Pharmaceutical Sciences, University of Tübingen, Germany, spoke to JFK Huber ...

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

We are going to pay the lowest price there is in the world,” Trump said before signing the executive order, which was met with skepticism.

President demands that drug companies start bringing costs ‘in line’ with those in other nations.